Trials / Completed
CompletedNCT02546375
A Study To Describe The Real World Use Of Bosutinib In The UK And Netherlands
A RETROSPECTIVE OBSERVATIONAL RESEARCH STUDY TO DESCRIBE THE REAL WORLD USE OF BOSUTINIB IN THE UK AND NETHERLANDS
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 87 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to describe the efficacy and safety of bosutinib in patients with chronic myeloid leukaemia used in a real world setting
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bosutinib | Bosutinib 100mg film-coated tablets; Bosutinib 500mg film-coated tablets Dosage as prescribed at treating institution; (observational study) |
Timeline
- Start date
- 2015-07-15
- Primary completion
- 2017-01-16
- Completion
- 2017-01-16
- First posted
- 2015-09-10
- Last updated
- 2023-10-03
- Results posted
- 2018-09-13
Locations
3 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02546375. Inclusion in this directory is not an endorsement.